Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters-a B-SAFE approach.

Journal of robotic surgery·2025
Same author

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

European heart journal·2021
Same author

Vascular-induced lung injury: another advocate for personalized ARDS management : Discussion on "Inspiratory preload obliteration may injure lungs via cyclical 'on-off' vascular flow".

Intensive care medicine·2018
Same author

Inspiratory preload obliteration may injure lungs via cyclical "on-off" vascular flow.

Intensive care medicine·2017
Same journal

Dr Archibald Hewan (1832-1883) and the University of Glasgow's medical libraries.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Joyce Grainger Learning Centre.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Features in this issue.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumab.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Leptospiral infection overlapping with autoimmune hepatitis: A diagnostic conundrum.

The journal of the Royal College of Physicians of Edinburgh·2025
Same journal

Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study.

The journal of the Royal College of Physicians of Edinburgh·2025
See all related articles

Related Experiment Video

Updated: May 31, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Randomised controlled trials: important but overrated?

J F Boylan1, B P Kavanagh, J Armitage

  • 1St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. jboylan@iol.ie

The Journal of the Royal College of Physicians of Edinburgh
|June 17, 2011
PubMed
Summary
This summary is machine-generated.

Randomized controlled trials (RCTs) are crucial for medical evidence, but clinicians face challenges applying RCT data to individual patient care. Bayesian methods and improved RCT quality offer ways to enhance treatment decisions.

More Related Videos

Application of Bedside Lower Extremity Rehabilitation Robots in Stroke Rehabilitation: A Randomized Controlled Trial
04:38

Application of Bedside Lower Extremity Rehabilitation Robots in Stroke Rehabilitation: A Randomized Controlled Trial

Published on: November 28, 2025

Related Experiment Videos

Last Updated: May 31, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Application of Bedside Lower Extremity Rehabilitation Robots in Stroke Rehabilitation: A Randomized Controlled Trial
04:38

Application of Bedside Lower Extremity Rehabilitation Robots in Stroke Rehabilitation: A Randomized Controlled Trial

Published on: November 28, 2025

Area of Science:

  • Medical research methodology
  • Clinical decision-making
  • Evidence-based medicine

Background:

  • Physicians individualize treatments to optimize patient outcomes by considering specific patient variables.
  • Randomized controlled trials (RCTs) are the gold standard for comparative effectiveness research.
  • Clinicians sometimes question the applicability of RCT findings to individual patients, especially when treatments performing worse in RCTs might benefit specific individuals.

Purpose of the Study:

  • To explore the interpretation of RCT data for practicing clinicians making individualized patient treatment choices.
  • To discuss the limitations of RCTs in guiding personalized medicine and to propose complementary approaches.

Main Methods:

  • The article presents a debate featuring two perspectives on interpreting RCT data.
  • One perspective, by John Boylan and Brian Kavanagh, highlights the dangers of bias in RCTs and advocates for Bayesian approaches to improve probability estimates by incorporating prior knowledge.
  • The second perspective, by Jane Armitage, defends the essential role of RCTs and suggests improvements through systematic reviews and avoidance of selective reporting to enhance randomization quality.

Main Results:

  • Bayesian methods can enhance the interpretation of RCT data by integrating prior probabilities with trial results to yield more accurate posterior probability estimates.
  • Systematic reviews and rigorous adherence to reporting standards can improve the quality and reliability of RCTs.
  • The discussion underscores the tension between generalizable evidence from RCTs and the need for individualized patient care.

Conclusions:

  • While RCTs remain indispensable for establishing treatment efficacy, their direct application to individual patients requires careful consideration.
  • Bayesian statistical approaches offer a valuable framework for refining treatment decisions by combining prior information with RCT evidence.
  • Enhancing the quality and transparency of RCTs through methods like systematic reviews is crucial for strengthening their utility in clinical practice.